ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,466Medicare Part D Prescriptions Filled, Including Refills

Rank: 61 out of 1802

$519K Total Retail Price of All Prescriptions

Rank: 82 out of 1802

341 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 341 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

9% of this provider’s 341 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 8,161 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
WARFARIN SODIUM 707 628 1 7
SIMVASTATIN 485 387 2 1
FUROSEMIDE 449 373 3 5
NAMENDA 349 325 4 34
LISINOPRIL 345 296 5 3
OMEPRAZOLE 320 269 6 4
LEVOTHYROXINE SODIUM 314 263 7 2
METOPROLOL TARTRATE 278 229 8 9
CITALOPRAM HBR 276 233 9 17
METFORMIN HCL 249 209 10 11
DONEPEZIL HCL 210 199 11 26
LOVASTATIN 176 146 12 25
LANTUS 165 90 13 47
AMLODIPINE BESYLATE 149 124 14 6
PREDNISONE 142 142 15 33
RISPERIDONE 140 123 16 64
FENTANYL 127 124 S2 17 43
ATENOLOL 122 110 18 12
HYDROCODONE-ACETAMINOPHEN 122 78 S3 18 10
GABAPENTIN 121 63 20 16
HYDROCHLOROTHIAZIDE 121 110 20 8
ATORVASTATIN CALCIUM 113 77 22 14
ALLOPURINOL 112 55 23 24
LOSARTAN POTASSIUM 109 87 24 18
NOVOLOG 101 43 25 100
ALENDRONATE SODIUM 93 93 26 21
SERTRALINE HCL 88 65 27 20
POTASSIUM CHLORIDE 86 73 28 15
CARVEDILOL 80 57 29 36
OXYCODONE-ACETAMINOPHEN 78 58 S2 30 67
MIRTAZAPINE 75 75 31 38
DIGOXIN 74 74 32 45
ARICEPT 74 74 32 296
AZITHROMYCIN 70 61 34 65
METOPROLOL SUCCINATE 70 58 34 13
TAMSULOSIN HCL 67 44 36 28
CARBIDOPA-LEVODOPA 61 37 37 70
GLYBURIDE 61 51 R 37 68
ZOLPIDEM TARTRATE 60 30 39 27
KLOR-CON M20 59 49 40 86
LOPERAMIDE 57 55 41 214
CEPHALEXIN 55 47 42 162
TRAMADOL HCL 55 26 42 22
ADVAIR DISKUS 55 30 42 32
NEXIUM 50 11 45 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 15, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.